Resident cracks security combo with Morse code knowledge, translates into fine for community
By
Kimberly Bonvissuto
May 04, 2021
A Tennessee senior living community was fined $2,000 by the state after two residents eloped from the memory care unit undetected last spring.
Changes in movement may indicate preclinical Alzheimer’s disease
Jul 02, 2021
Changes in daytime fractal motor activity regulation may occur in women before cognitive symptoms of Alzheimer’s disease.
Researchers work on affordable, non-invasive Alzheimer’s test
By
Lois A. Bowers
Jul 16, 2015
New research is attempting to identify a potential biomarker that could offer a more complete picture of who is most at risk of developing Alzheimer’s disease among those who have amnestic mild cognitive...
More news for Monday, June 12
By
Kimberly Bonvissuto
Jun 12, 2023
Convicted serial killer Billy Chemirmir appealing a capital murder conviction … FDA panel says new data support ‘full’ approval of Alzheimer’s drug Leqembi … Succession planning still lacking...
Memory care provider fined $10,500, almost loses license over pandemic-related safety citations
By
Kimberly Bonvissuto
Jul 15, 2021
A senior living operator has been fined $10,500, but avoided a move to have its Florida operating license revoked, because a state health inspector said that a community did not provide a “safe and decent...
CDC: 14% of those 75+ have early symptom of Alzheimer’s
By
Lois A. Bowers
Jul 17, 2018
Fourteen percent of adults aged 75 or more years have subjective cognitive decline, one of the earliest noticeable symptoms of Alzheimer’s disease, according to new data from the Centers for Disease...
Anthem making progress under LTC Properties’ watchful eye
By
Lois A. Bowers
May 11, 2018
Anthem Memory Care continues to make progress on community occupancy and leadership stability, LTC Properties’ Chairman, President and CEO Wendy Simpson said Thursday during a first-quarter 2018...
Pfizer to end Alzheimer’s, Parkinson’s research
By
Lois A. Bowers
Jan 09, 2018
Pharmaceutical company Pfizer has announced that it will end its research and development programs for Alzheimer’s and Parkinson’s treatments and “re-allocate funding to those areas where...
High ratings fuel recognition for 1,600 senior living operators
By
John O'Connor
Dec 14, 2017
SeniorAdvisor.com announced that more than 1,600 senior living communities have been recognized as among the best in the business.
Alzheimer’s experts throw support behind experimental drug despite adverse events, deaths
By
Kimberly Bonvissuto
Dec 01, 2022
Alzheimer’s disease experts are throwing their support behind the drug lecanemab, despite reports of two deaths tied to the experimental monoclonal antibody medication.